Pharmacovigilance has to be conducted with the realization that behind every adverse reaction report there is a patient's face and one seeks to avoid that face reflecting the effects of serious iatrogenic disease. Table 36.5 and the data given above suggest that this has been largely achieved in respect of haemopoietic ADRs associated with the use of phenylbutazone. In the United Kingdom the ADROIT database facilitates continued observation to preserve and augment this type of improvement.

Was this article helpful?

0 0
Drug Free Life

Drug Free Life

How To Beat Drugs And Be On Your Way To Full Recovery. In this book, you will learn all about: Background Info On Drugs, Psychological Treatments Statistics, Rehab, Hypnosis and Much MORE.

Get My Free Ebook

Post a comment